Cater Michael A, La Fontaine Sharon, Shield Kristy, Deal Yolanda, Mercer Julian F B
Centre for Cellular and Molecular Biology, School of Biological and Chemical Sciences, Deakin University, Burwood, Australia.
Gastroenterology. 2006 Feb;130(2):493-506. doi: 10.1053/j.gastro.2005.10.054.
BACKGROUND & AIMS: The Wilson protein (ATP7B) regulates levels of systemic copper by excreting excess copper into bile. It is not clear whether ATP7B translocates excess intrahepatic copper directly across the canalicular membrane or sequesters this copper into exocytic vesicles, which subsequently fuse with canalicular membrane to expel their contents into bile. The aim of this study was to clarify the mechanism underlying ATP7B-mediated copper detoxification by investigating endogenous ATP7B localization in the HepG2 hepatoma cell line and its ability to mediate vesicular sequestration of excess intracellular copper.
Immunofluorescence microscopy was used to investigate the effect of copper concentration on the localization of endogenous ATP7B in HepG2 cells. Copper accumulation studies to determine whether ATP7B can mediate vesicular sequestration of excess intracellular copper were performed using Chinese hamster ovary cells that exogenously expressed wild-type and mutant ATP7B proteins.
In HepG2 cells, elevated copper levels stimulated trafficking of ATP7B to pericanalicular vesicles and not to the canalicular membrane as previously reported. Mutation of an endocytic retrieval signal in ATP7B caused the protein to constitutively localize to vesicles and not to the plasma membrane, suggesting that a vesicular compartment(s) is the final trafficking destination for ATP7B. Expression of wild-type and mutant ATP7B caused Chinese hamster ovary cells to accumulate copper in vesicles, which subsequently undergo exocytosis, releasing copper across the plasma membrane.
This report provides compelling evidence that the primary mechanism of biliary copper excretion involves ATP7B-mediated vesicular sequestration of copper rather than direct copper translocation across the canalicular membrane.
威尔逊蛋白(ATP7B)通过将过量铜排泄到胆汁中来调节全身铜水平。目前尚不清楚ATP7B是直接将肝内过量铜转运穿过胆小管膜,还是将这种铜隔离到胞吐小泡中,随后小泡与胆小管膜融合以将其内容物排入胆汁。本研究的目的是通过研究内源性ATP7B在HepG2肝癌细胞系中的定位及其介导细胞内过量铜的小泡隔离能力,阐明ATP7B介导铜解毒的机制。
采用免疫荧光显微镜研究铜浓度对HepG2细胞内源性ATP7B定位的影响。使用外源性表达野生型和突变型ATP7B蛋白的中国仓鼠卵巢细胞进行铜积累研究,以确定ATP7B是否能介导细胞内过量铜的小泡隔离。
在HepG2细胞中,铜水平升高刺激ATP7B转运至胆小管周围小泡,而非如先前报道的转运至胆小管膜。ATP7B中一个内吞回收信号的突变导致该蛋白组成性地定位于小泡而非质膜,这表明一个小泡区室是ATP7B的最终转运目的地。野生型和突变型ATP7B的表达导致中国仓鼠卵巢细胞在小泡中积累铜,随后小泡发生胞吐作用,将铜释放穿过质膜。
本报告提供了有力证据,表明胆汁铜排泄的主要机制涉及ATP7B介导的铜小泡隔离,而非铜直接穿过胆小管膜的转运。